Please see below for an update from the International Union for Basic and Clinical Pharmacology (IUPHAR)
Clinical Division considerations in the context of COVID-19 pandemics
IUPHAR Clinical Division: Caroline Samer (Switzerland), David Webb (UK), Guido Mannaioni (Italy),
Hiroshi Watanabe (Japan), Jae Gook Shin (Korea), Jamie Coleman (UK), Maria Isabel Lucena (Spain),
Matthew Doogue (NZ), Nilima Kshirsagar (India), Olayinka Ogunleye (Nigeria), Sarah Hilmer (Australia),
Wei Wei (China).